Table 4.
Median costs of outpatients and inpatients with herpes zoster by patient characteristics
| Characteristic | Outpatients | Inpatients | |||||
|---|---|---|---|---|---|---|---|
| N | PHN, n (%) | Median cost, CNY | N | PHN, n (%) | Median cost, CNY | ||
| Sex | |||||||
| Female | 58,399 | 9,090 (15.6) | 122.8 (43.0–361.3) | 5,729 | 945 (16.5) | 6,235.3 (4,028.7–8,915.7) | |
| Male | 52,316 | 8,356 (16.0) | 131.0 (45.9–371.5) | 5,147 | 847 (16.5) | 6,346.6 (4,048.6–9,271.6) | |
| Age group (years) | |||||||
| <40 | 20,372 | 1,976 (9.7) | 142.4 (53.6–357.1) | 1,041 | 88 (8.5) | 5,727.9 (3,736.3–7,733.1) | |
| 40–49 | 15,597 | 2,181 (14.0) | 139.6 (48.1–383.3) | 1,044 | 100 (9.6) | 5,817.9 (3,780.0–8,109.6) | |
| 50–59 | 25,326 | 3,864 (15.3) | 123.9 (44.2–359.4) | 2,698 | 404 (15.0) | 5,827.8 (3,623.4–8,438.2) | |
| 60–69 | 28,161 | 5,012 (17.8) | 115.3 (40.1–360.1) | 3,116 | 605 (19.4) | 6,729.8 (4,304.5–9,664.7) | |
| ≥70 | 21,259 | 4,413 (20.8) | 119.5 (40.1–382.0) | 2,977 | 595 (20.0) | 6,701.5 (4,350.2–10,066.6) | |
| PHN status | |||||||
| No | 93,269 | 0 (0.0) | 119.3 (43.0–337.3) | 9,084 | 0 (0.0) | 6,058.1 (3,921.0–8,807.1) | |
| Yes | 17,446 | 17,446 (100.0) | 185.0 (51.9–548.2) | 1,792 | 1,792 (100.0) | 7,442.9 (4,951.7–10,560.2) | |
| Healthcare facility type | |||||||
| Primary healthcare institutions | 50,729 | 7,171 (14.1) | 66.7 (29.9–133.7) | 619 | 60 (9.7) | 3,743.4 (2,503.2–5,555.3) | |
| Secondary or higher-level hospitals | 59,986 | 10,275 (17.1) | 266.0 (96.4–656.7) | 10,257 | 1,732 (16.9) | 6,460.0 (4,193.4–9,251.8) | |
| Number of visits | |||||||
| 1 | 88,599 | 12,264 (13.8) | 90.1 (32.9–214.5) | 8,728 | 1,241 (14.2) | 5,807.5 (3,815.3–8,437.7) | |
| ≥ 2 | 22,116 | 5,182 (23.4) | 735.0 (344.1–1,349.9) | 2,148 | 551 (25.7) | 8,430.8 (5,792.5–11,732.3) | |
| Length of stay (days) | |||||||
| ≤ 7 | 4485 | 599 (13.4) | 4,215.8 (2,959.8–5,888.1) | ||||
| 8–13 | 4816 | 817 (17.0) | 7,214.0 (5,277.2–9,189.8) | ||||
| ≥ 14 | 1,575 | 376 (23.9) | 12,573.9 (9,757.6–17,352.0) | ||||
| Total | 110,715 | 17,446 (15.8) | 126.7 (44.4–365.6) | 10,876 | 1,792 (16.5) | 6,290.2 (4,038.4–9,093.6) | |
Abbreviations: Values in parentheses are presented as IQRs; PHN status is shown for completeness; PHN proportions in other strata are calculated within each category; Number of visits refers to HZ-related visits defined by herpes zoster as the primary diagnosis